- Home
- NPV vs SWKH Comparison
NPV vs SWKH Comparison
Compare NPV & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPV
- SWKH
- Stock Information
- Founded
- NPV 1993
- SWKH 1996
- Country
- NPV United States
- SWKH United States
- Employees
- NPV N/A
- SWKH N/A
- Industry
- NPV Investment Managers
- SWKH Diversified Financial Services
- Sector
- NPV Finance
- SWKH Finance
- Exchange
- NPV Nasdaq
- SWKH Nasdaq
- Market Cap
- NPV 199.1M
- SWKH 179.1M
- IPO Year
- NPV N/A
- SWKH 1999
- Fundamental
- Price
- NPV $11.46
- SWKH $14.58
- Analyst Decision
- NPV
- SWKH Strong Buy
- Analyst Count
- NPV 0
- SWKH 1
- Target Price
- NPV N/A
- SWKH $18.00
- AVG Volume (30 Days)
- NPV 38.9K
- SWKH 12.2K
- Earning Date
- NPV 01-01-0001
- SWKH 08-14-2025
- Dividend Yield
- NPV 3.90%
- SWKH N/A
- EPS Growth
- NPV N/A
- SWKH 55.18
- EPS
- NPV N/A
- SWKH 1.41
- Revenue
- NPV N/A
- SWKH $37,409,000.00
- Revenue This Year
- NPV N/A
- SWKH $52.93
- Revenue Next Year
- NPV N/A
- SWKH N/A
- P/E Ratio
- NPV N/A
- SWKH $10.36
- Revenue Growth
- NPV N/A
- SWKH 47.31
- 52 Week Low
- NPV $8.92
- SWKH $12.00
- 52 Week High
- NPV $11.55
- SWKH $16.24
- Technical
- Relative Strength Index (RSI)
- NPV 74.17
- SWKH 47.08
- Support Level
- NPV $11.25
- SWKH $14.38
- Resistance Level
- NPV $11.37
- SWKH $15.20
- Average True Range (ATR)
- NPV 0.08
- SWKH 0.29
- MACD
- NPV 0.03
- SWKH 0.04
- Stochastic Oscillator
- NPV 98.91
- SWKH 51.56
About NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities.
About SWKH SWK Holdings Corporation
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.